Mpox vaccine for adolescents and eight new medicines receive EMA approval
The European Medicines Agency’s (EMA) human medicines committee has authorised the use of Bavarian Nordic’s mpox vaccine Imvanex for adolescents.
Imvanex
France updates mpox’s vaccination strategy
France has updated its vaccination recommendations in the face of a rise in mpox cases in Central Africa linked to the clade I and clade Ib variants, despite the low risk of the virus being introduced into the country.